It shows that most times, there can be a healthy difference noticeable from the start
reduction in fasting blood glucose
Study identifies gut-brain-immune network influencing effectiveness of GLP-1 agonists owenhaskins Dec 19, 2023 3 min read Researchers at the Lunenfeld-Tanenbaum Research Institute, part of Sinai Health, have discovered a gut-brain-immune network and posit a new gut-brain glucagon-like peptide 1 (GLP-1R) that controls inflammation across the body, a discovery which holds promise for understanding and treating metabolic diseases
Under normal circumstances, only a small portion of fructose-6-phosphate from glycolysis enters this pathway, where it is changed into glucosamine-6-phosphate by the enzyme glutamine fructose-6-phosphate amidotransferase (66)
Am J Clin Nutr 77:185188 Dalle-Donne I, Rossi R, Giustarini D, Milzani A, Colombo R (2003) Protein carbonyl groups as biomarkers of oxidative stress
Am J Physiol Regul Integr Comp Physiol 2012;302:R751-R767